Skip to Main Content

2,264

Views

1

CrossRef citations to date

0

Altmetric

Original Research

Improvement in clinical disease activity index when treatment selection is informed by the tumor necrosis factor-ɑ inhibitor molecular signature response classifier: analysis from the study to accelerate information of molecular signatures in rheumatoid arthritis

Vibeke Stranda Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USAView further author information

,

Lixia Zhangb Scipher Medicine Corporation, Waltham, MA, USAView further author information

,

Alix Arnaudb Scipher Medicine Corporation, Waltham, MA, USAView further author information

,

Erin Connolly-Strongb Scipher Medicine Corporation, Waltham, MA, USAView further author information

,

Sam Asgarianb Scipher Medicine Corporation, Waltham, MA, USAView further author information

&

Johanna B Withersb Scipher Medicine Corporation, Waltham, MA, USACorrespondence[email protected]

https://orcid.org/0000-0003-1289-4454 View further author information